KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) EPS (Basic): 2015-2025

Historic EPS (Basic) for BeOne Medicines (ONC) over the last 11 years, with Sep 2025 value amounting to $0.09.

  • BeOne Medicines' EPS (Basic) rose 200.00% to $0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.05, marking a year-over-year increase of 107.96%. This contributed to the annual value of -$0.47 for FY2024, which is 27.69% up from last year.
  • Latest data reveals that BeOne Medicines reported EPS (Basic) of $0.09 as of Q3 2025, which was up 28.57% from $0.07 recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' EPS (Basic) registered a high of $0.16 during Q3 2023, and its lowest value of -$0.49 during Q4 2021.
  • Moreover, its 3-year median value for EPS (Basic) was -$0.09 (2024), whereas its average is -$0.09.
  • Per our database at Business Quant, BeOne Medicines' EPS (Basic) tumbled by 650.00% in 2022 and then surged by 200.00% in 2025.
  • Over the past 5 years, BeOne Medicines' EPS (Basic) (Quarterly) stood at -$0.49 in 2021, then soared by 32.65% to -$0.33 in 2022, then climbed by 18.18% to -$0.27 in 2023, then skyrocketed by 59.26% to -$0.11 in 2024, then spiked by 200.00% to $0.09 in 2025.
  • Its last three reported values are $0.09 in Q3 2025, $0.07 for Q2 2025, and $0.00 during Q1 2025.